Sunday, December 07, 2025 | 03:42 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

30 groups in India working on coronavirus vaccine, 20 at 'good pace'

ICMR conducting study on presence of antibodies in people, results next week

Serum institute, coronavirus, vaccine, pharma, drugs
premium

One of the vaccines being developed on the backbone of a flu vaccine will be in the preclinical stage by October, Principal Scientific Advisor K Vijay Raghavan said while highlighting that India's vaccine manufacturing capabilities were world class.

Ruchika Chitravanshi New Delhi
India will have capacity to make half a million diagnostic test kits a day by July, Empowered Group-1 Chairman V K Paul looking at medical emergency management said on Thursday.

"Twenty companies are making these kits in India, and once our requirements are met they can send these kits to other countries," Paul said.

He said eight vaccine candidates being worked on, of which four were ahead of others. Also, the national science lab is testing six vaccine candidates, of which two-three are showing promise.  There are 30 groups in India that are working towards developing vaccines, of which 20